Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade F 78.66 0.65% 0.51
ABBV closed up 0.65 percent on Tuesday, April 23, 2019, on 1.65 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Apr 25

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ABBV trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 0.65%
Oversold Stochastic Weakness 0.65%
Lower Bollinger Band Walk Weakness 1.41%
Below Lower BB Weakness 1.41%
Down 3 Days in a Row Weakness 1.41%
Lower Bollinger Band Touch Weakness 1.41%
Oversold Stochastic Weakness 1.41%

Older signals for ABBV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Chemistry Chemical Compounds Organic Compounds Pharmaceutical Products Autoimmune Diseases Prostate Cancer Chloroarenes Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Lipoproteins Secondary Hyperparathyroidism Celiac Disease Exocrine Pancreatic Insufficiency Hypothyroidism Research Based Biopharmaceutical Testosterone Replacement Therapy
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 107.25
52 Week Low 75.77
Average Volume 5,566,701
200-Day Moving Average 87.6137
50-Day Moving Average 80.253
20-Day Moving Average 81.008
10-Day Moving Average 80.179
Average True Range 1.6084
ADX 18.0
+DI 20.1374
-DI 28.2255
Chandelier Exit (Long, 3 ATRs ) 79.9048
Chandelier Exit (Short, 3 ATRs ) 81.6352
Upper Bollinger Band 84.7965
Lower Bollinger Band 77.2195
Percent B (%b) 0.19
BandWidth 9.353397
MACD Line -0.5496
MACD Signal Line -0.0309
MACD Histogram -0.5187
Fundamentals Value
Market Cap 125.4 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 19.33
Price-to-Sales 5.35
Price-to-Book 23.76
PEG Ratio 1.00
Dividend 2.56
Dividend Yield 3.25%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.53
Resistance 3 (R3) 81.54 80.60 81.05
Resistance 2 (R2) 80.60 79.87 80.59 80.89
Resistance 1 (R1) 79.63 79.42 80.12 79.62 80.73
Pivot Point 78.69 78.69 78.93 78.68 78.69
Support 1 (S1) 77.72 77.96 78.21 77.71 76.59
Support 2 (S2) 76.78 77.51 76.77 76.43
Support 3 (S3) 75.81 76.78 76.27
Support 4 (S4) 75.80